Product Information

MEFLOQUINE HCL 250 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $3.7313 per EA under NDC 00555017178. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Dec 29, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MEFLOQUINE HCL 250 MG TABLET

Mefloquine Hydrochloride
$3.7313per EA

Strength

250 mg/1

NDC

00555017178

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

MEFLOQUINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA076392

FDA Approved

12/29/2003

TE Code

AB

On Market Since

1/6/2004

Pharmacological Classes

Price Statistics

The NADAC for MEFLOQUINE HCL 250 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 23.5%. The table below summarizes its recorded NADAC range and movement.

Current price$3.7313 per EA
All-time high$6.3637 (Sep 10, 2014)
All-time low$2.8103 (Aug 23, 2023)
52-week high$4.8735
52-week low$3.7313
Median price$4.0719
Average price$4.2078
Largest weekly change+52.2% (Aug 20, 2025)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-6.1%

3M

-9.3%

6M

-12.4%

1Y

-24.6%

3Y

-2.1%

5Y

-29.6%

All

-23.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MEFLOQUINE HCL 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MEFLOQUINE HCL 250 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $3.7313 per EA (NDC 00555017178), effective Nov 11, 2026.

How has the price of MEFLOQUINE HCL 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for MEFLOQUINE HCL 250 MG TABLET has declined 23.5%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MEFLOQUINE HCL 250 MG TABLET?

Since Nov 28, 2013, the NADAC for MEFLOQUINE HCL 250 MG TABLET has ranged from a low of $2.8103 (Aug 23, 2023) to a high of $6.3637 (Sep 10, 2014), with a median of $4.0719 per EA.

Are there cheaper alternatives to MEFLOQUINE HCL 250 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MEFLOQUINE HCL 250 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MEFLOQUINE HCL 250 MG TABLET?

MEFLOQUINE HCL 250 MG TABLET (NDC 00555017178) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.